Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathway

Zhijun Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongsheng Liu(Peking Union Medical College Hospital)
Oncology Reports
September 4, 2017
Cited by 56


Related Papers